|
🐢
|
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
14 auth.
R. Carhart-Harris,
M. Bolstridge,
J. Rucker,
C. Day,
D. Erritzoe,
M. Kaelen,
M. Bloomfield,
J. Rickard,
Ben Forbes,
A. Feilding,
...
David Taylor,
S. Pilling,
V. Curran,
D. Nutt
|
9 |
2016 |
9
🐢
|
|
🐢
|
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
19 auth.
R. Carhart-Harris,
M. Bolstridge,
M. Bolstridge,
C. Day,
C. Day,
J. Rucker,
J. Rucker,
R. Watts,
D. Erritzoe,
M. Kaelen,
...
B. Giribaldi,
M. Bloomfield,
S. Pilling,
J. Rickard,
Ben Forbes,
A. Feilding,
D. Taylor,
H. Curran,
D. Nutt
|
9 |
2017 |
9
🐢
|
|
🐜
|
Homological scaffolds of brain functional networks
7 auth.
G. Petri,
P. Expert,
F. Turkheimer,
R. Carhart-Harris,
D. Nutt,
Peter J Hellyer,
...
F. Vaccarino
|
9 |
2014 |
9
🐜
|
|
🐜
|
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders
110 auth.
Jenny C. Taylor,
H. Martin,
S. Lise,
J. Broxholme,
J. Cazier,
A. Rimmer,
Alexander Kanapin,
G. Lunter,
S. Fiddy,
C. Allan,
A. Aricescu,
M. Attar,
C. Babbs,
J. Becq,
D. Beeson,
...
C. Bento,
P. Bignell,
E. Blair,
V. Buckle,
Katherine R. Bull,
O. Cais,
H. Cario,
H. Chapel,
R. Copley,
R. Cornall,
Jude Craft,
K. Dahan,
E. Davenport,
C. Dendrou,
O. Devuyst,
A. Fenwick,
J. Flint,
L. Fugger,
R. Gilbert,
A. Goriely,
A. Green,
I. Greger,
R. Grocock,
A. Gruszczyk,
R. Hastings,
E. Hatton,
D. Higgs,
A. Hill,
Chris Holmes,
Malcolm F. Howard,
L. Hughes,
P. Humburg,
David Johnson,
F. Karpe,
Z. Kingsbury,
U. Kini,
J. Knight,
J. Krohn,
S. Lamble,
C. Langman,
L. Lonie,
J. Luck,
Davis J. McCarthy,
S. McGowan,
M. McMullin,
K. Miller,
L. Murray,
A. Nemeth,
M. Nesbit,
D. Nutt,
E. Ormondroyd,
A. Oturai,
A. Pagnamenta,
Smita Y. Patel,
M. Percy,
N. Petousi,
P. Piazza,
Sian E. Piret,
G. Polanco-Echeverry,
N. Popitsch,
F. Powrie,
C. Pugh,
L. Quek,
P. Robbins,
K. Robson,
A. Russo,
N. Sahgal,
P. V. van Schouwenburg,
A. Schuh,
E. Silverman,
A. Simmons,
P. Sørensen,
E. Sweeney,
John M. Taylor,
R. Thakker,
I. Tomlinson,
A. Trebes,
S. Twigg,
H. Uhlig,
P. Vyas,
T. Vyse,
S. Wall,
H. Watkins,
M. Whyte,
L. Witty,
B. Wright,
C. Yau,
D. Buck,
S. Humphray,
P. Ratcliffe,
J. Bell,
A. Wilkie,
D. Bentley,
P. Donnelly,
G. McVean
|
8 |
2015 |
8
🐜
|
|
🐜
|
LSD‐induced entropic brain activity predicts subsequent personality change
7 auth.
A. Lebedev,
M. Kaelen,
M. Lövdén,
Jonna Nilsson,
A. Feilding,
D. Nutt,
...
R. Carhart-Harris
|
8 |
2016 |
8
🐜
|
|
🐜
|
Increased global integration in the brain after psilocybin therapy for depression
9 auth.
Richard E. Daws,
C. Timmermann,
B. Giribaldi,
J. D. Sexton,
M. Wall,
D. Erritzoe,
...
L. Roseman,
D. Nutt,
R. Carhart-Harris
|
7 |
2022 |
7
🐜
|
|
🐢
|
A web-based survey on mephedrone.
R. Carhart-Harris,
L. King,
D. Nutt
|
7 |
2011 |
7
🐢
|
|
🐢
|
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
8 auth.
R. Carhart-Harris,
M. Kaelen,
M. Bolstridge,
T. Williams,
Luke T. J. Williams,
Raphael Underwood,
...
A. Feilding,
D. Nutt
|
7 |
2016 |
7
🐢
|
|
🐜
|
Neural substrates of cue reactivity and craving in gambling disorder
18 auth.
Eve H. Limbrick-Oldfield,
Eve H. Limbrick-Oldfield,
I. Mick,
Rachel Cocks,
Rachel Cocks,
J. McGonigle,
Steve Sharman,
Steve Sharman,
A. Goldstone,
P. Stokes,
...
P. Stokes,
A. Waldman,
D. Erritzoe,
H. Bowden-Jones,
D. Nutt,
A. Lingford-Hughes,
L. Clark,
L. Clark
|
7 |
2017 |
7
🐜
|
|
🐬
|
5‐HT radioligands for human brain imaging with PET and SPECT
L. Paterson,
B. Kornum,
D. Nutt,
V. Pike,
G. Knudsen
|
7 |
2013 |
7
🐬
|
|
🐢
|
A Lifetime Prevalence of Comorbidity Between Bipolar Affective Disorder and Anxiety Disorders: A Meta-analysis of 52 Interview-based Studies of Psychiatric Population
B. Nabavi,
A. Mitchell,
D. Nutt
|
6 |
2015 |
6
🐢
|
